Investor Presentation slide image

Investor Presentation

Well Positioned for Sustainable Growth (0) Four main franchises focused on technology leadership High impact systems and consumable products for flexible manufacturing; single-use and continuous solutions Total addressable market: ~$3.7B Expanding manufacturing capacity to stay ahead of increasing demand. R&D engine for next-generation products Strong end market acceleration, diversification Growth Rates 2021e by Franchise FILTRATION >100% ANALYTICS 30%-35% CHROMA 35%-45% PROTEINS >30% RREPLIGEN INSPIRING ADVANCES IN BIOPROCESSING Cash & Equivalents $740M-$750M YE 2021e 2024 Revenue Goal $1.0 Billion 23
View entire presentation